J&J's Janssen Says 3rd Circ. Should Reverse $1.6B FCA Win

By Jarek Rutz · October 30, 2025, 7:06 PM EDT

Johnson & Johnson's Janssen Products LP urged the Third Circuit to overturn a $1.6 billion False Claims Act judgment over two of its HIV drugs, arguing the district court allowed whistleblowers...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login